CN104491319A - Traditional Chinese medicine composition treating hyperosteogeny and preparation method thereof - Google Patents
Traditional Chinese medicine composition treating hyperosteogeny and preparation method thereof Download PDFInfo
- Publication number
- CN104491319A CN104491319A CN201410608117.8A CN201410608117A CN104491319A CN 104491319 A CN104491319 A CN 104491319A CN 201410608117 A CN201410608117 A CN 201410608117A CN 104491319 A CN104491319 A CN 104491319A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition treating hyperosteogeny and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following bulk drugs in parts by weight: 5-15 parts of scolopendra, 6-12 parts of scorpio, 8-12 parts of hippocampus, 18-25 parts of radix aconiti kusnezoffii preparata, 10-15 parts of radix angelicae sinensis, 5-8 parts of radix astragali, 6-14 parts of cortex eucommiae, 5-13 parts of radix rehmanniae, 5-9 parts of fried rhizoma atractylodis macrocephalae, 12-18 parts of chinese alangium root, 15-19 parts of indian bread with pine, 10-15 parts of madder root, 20-25 parts of radix aconiti preparata, 15-20 parts of radix glycyrrhizae, 25-35 parts of rhizoma arisaematis preparata, 12-16 parts of costustoot, 9-14 parts of radix rehmanniae preparata, 10-25 parts of radix angelicae pubescentis, 5-15 parts of semen trigonellae, and 10-15 parts of rhizoma dioscoreae. When the traditional Chinese medicine composition is prepared, the above bulk drugs are put in pure rice wine for immersion. The bulk drugs complement each other and are capable of dispelling wind and activating collaterals, and the prepared traditional Chinese medicine composition gives play to extremely good effect of treating hyperosteogeny, is fast in effectiveness and short in treatment time, has the cure rate up to 90% or more, and has extremely good effect on treating rheumatism.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of hyperosteogeny and preparation method thereof.
Background technology
Hyperosteogeny is a kind of commonly encountered diseases, the main cause of hyperosteogeny morbidity is because calcium deficiency causes osteoporosis, loosen in joint, articular cartilage is changed in quality and is come off, sclerotin exposed and abraded thus form hyperosteogeny long bone thorn, marrow cavity pressure increases, and bony spur excites nerve and causes pain, and major part is more the people of 40 years old to more than 50 years old.The Therapeutic Principle of doctor trained in Western medicine is antiinflammatory, analgesia, and by some antibiotic medicine or analgesic treatment hyperosteogeny, and the traditional Chinese medical science is mainly with invigorating the liver and kidney, wind-damp dispelling, reducing swelling and alleviating pain, and relaxing muscles and tendons to promote blood circulation is main, is aided with existing Chinese herbal medicine and treats.
Chinese medicine is the rarity of China's accumulation of culture in 5000, before the Qing Dynasty, compatriots are promoted health and cured diseases all based on the various preparations of Chinese herbal medicine, the theory that the traditional Chinese medical science is unique together with Chinese medicine and mode generation succession of making a study of subjects, for indelible contribution has been made in the procreation of Chinese nation's life and growth in nature and growth.And by the Chinese medicine of building body and wine " molten " medicated wine in one, not only prepare convenience, the property of medicine is stable, safe and effective, because wine have the title of " length of hundred medicines ", and because ethanol is a kind of good semi-polarity organic solvent, the various effective ingredient of Chinese medicine are all soluble in wherein, wine assisting drug, wine help medicine gesture and give full play to its effect, improve curative effect.At present, occurred the medicated wine being much used for the treatment of various disease, such as, had the medicated wine of a lot for the treatment of hyperosteogeny, but the curative effect of these medicated wine is not very remarkable, the effective Traditional Chinese medicinal liquor of therefore preparation one is used for the treatment of hyperosteogeny and has very important significance.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of hyperosteogeny, effectively can play the effect for the treatment of hyperosteogeny, and be equipped with simple, have no side effect.
A kind of Chinese medicine composition for the treatment of hyperosteogeny, described Chinese medicine composition comprises the crude drug of following weight portion: Scolopendra 5 ~ 15 parts, Scorpio 6 ~ 12 parts, Hippocampus 8 ~ 12 parts, Radix Aconiti Kusnezoffii Preparata 18 ~ 25 parts, Radix Angelicae Sinensis 10 ~ 15 parts, the Radix Astragali 5 ~ 8 parts, the Cortex Eucommiae 6 ~ 14 parts, 5 ~ 13 parts, the Radix Rehmanniae, Rhizoma Atractylodis Macrocephalae (parched) 5 ~ 9 parts, Radix Alangii 12 ~ 18 parts, Poria cum Radix Pini 15 ~ 19 parts, Radix Rubiae 10 ~ 15 parts, Radix Aconiti Preparata 20 ~ 25 parts, 15 ~ 20 parts, Radix Glycyrrhizae, Rhizoma Arisaematis (processed) 25 ~ 35 parts, Radix Aucklandiae (Radix Vladimiriae) 12 ~ 16 parts, 9 ~ 14 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 10 ~ 25 parts, Semen Trigonellae 5 ~ 15 parts, Rhizoma Dioscoreae 10 ~ 15 parts.
As preferably, described Chinese medicine composition comprises the crude drug of following weight portion: Scolopendra 8 ~ 12 parts, Scorpio 10 ~ 12 parts, Hippocampus 8 ~ 10, Radix Aconiti Kusnezoffii Preparata 20 ~ 25 parts, Radix Angelicae Sinensis 10 ~ 13 parts, the Radix Astragali 6 ~ 8 parts, the Cortex Eucommiae 8 ~ 14 parts, 7 ~ 11 parts, the Radix Rehmanniae, Rhizoma Atractylodis Macrocephalae (parched) 7 ~ 9 parts, Radix Alangii 15 ~ 18 parts, Poria cum Radix Pini 17 ~ 19 parts, Radix Rubiae 12 ~ 15 parts, Radix Aconiti Preparata 22 ~ 25 parts, 18 ~ 20 parts, Radix Glycyrrhizae, Rhizoma Arisaematis (processed) 30 ~ 35 parts, Radix Aucklandiae (Radix Vladimiriae) 12 ~ 14 parts, 12 ~ 14 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 15 ~ 25 parts, Semen Trigonellae 10 ~ 15 parts, Rhizoma Dioscoreae 12 ~ 15 parts.
As more preferably, described Chinese medicine composition comprises the crude drug of following weight portion: Scolopendra 10 parts, Scorpio 12 parts, Hippocampus 10 parts, Radix Aconiti Kusnezoffii Preparata 23 parts, Radix Angelicae Sinensis 12 parts, the Radix Astragali 8 parts, the Cortex Eucommiae 13 parts, 10 parts, the Radix Rehmanniae, Rhizoma Atractylodis Macrocephalae (parched) 9 parts, Radix Alangii 17 parts, Poria cum Radix Pini 18 parts, Radix Rubiae 12 parts, Radix Aconiti Preparata 24 parts, 20 parts, Radix Glycyrrhizae, Rhizoma Arisaematis (processed) 35 parts, Radix Aucklandiae (Radix Vladimiriae) 13 parts, 14 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 18 parts, Semen Trigonellae 13 parts, Rhizoma Dioscoreae 15 parts.
As preferably, also comprise the pure rice wine that the number of degrees are 35 ~ 40.
Present invention also offers the preparation method of the Chinese medicine composition of above-mentioned treatment hyperosteogeny, comprise the following steps:
(1) Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui to soak, then the Rhizoma Atractylodis Macrocephalae (parched) taking-up after soaking is dried, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) becomes golden yellow;
(2) Scolopendra, Scorpio, Hippocampus are put among described pure rice wine and soak 1 ~ 3 day;
(3) step (1) gained Rhizoma Atractylodis Macrocephalae (parched) and remaining crude drug are put into step (2) described pure rice wine, soak 5 ~ 9 days.
Rhizoma Atractylodis Macrocephalae (parched) is carried out pre-treatment by the present invention, its harmful components are made to be dissolved in salt Jiang Shui, stir-fry to golden yellow through big fire again, its effective ingredient is made to be easier to be dissolved in pure rice wine, and the wine that the present invention selects is pure rice wine, it is not containing any adding ingredient, effectively can dissolve the effective ingredient in raw material of Chinese medicine, the present invention is first by Scolopendra, Scorpio, after Hippocampus is soaked in rice wine a period of time, its effective ingredient can be made more to be dissolved among pure rice wine, again remaining crude drug is dissolved with it, each component can be made to complement each other, more effective performance drug effect.
As preferably, the weight of described pure rice wine is 4 ~ 7kg.
As preferably, the time of soaking in described step (1) is 2 ~ 3 days.
As preferably, the time of soaking in described step (3) is 6 ~ 8 days.
Compared with prior art, beneficial effect of the present invention is embodied in:
The each crude drug of the present invention complements each other, dispelling, collateral-activating, and the Chinese medicine composition of preparation can be good at the effect playing treatment hyperosteogeny, its instant effect, required treatment time is short, and cure rate can reach more than 90%, and Chinese medicine composition of the present invention is to treatment rheumatism, also has extraordinary effect.
Detailed description of the invention
Embodiment 1
The preparation of crude drug: take Scolopendra 5g, Scorpio 12g, Hippocampus 9g, Radix Aconiti Kusnezoffii Preparata 18g, Radix Angelicae Sinensis 15g, Radix Astragali 8g, Cortex Eucommiae 7g, Radix Rehmanniae 12g, Rhizoma Atractylodis Macrocephalae (parched) 5g, Radix Alangii 18g, Poria cum Radix Pini 15g, Radix Rubiae 12g, Radix Aconiti Preparata 25g, Radix Glycyrrhizae 20g, Rhizoma Arisaematis (processed) 30g, Radix Aucklandiae (Radix Vladimiriae) 14g, Radix Rehmanniae Preparata 11g, Radix Angelicae Pubescentis 15g, Semen Trigonellae 12g, Rhizoma Dioscoreae 10g.Before wherein taking Rhizoma Atractylodis Macrocephalae (parched), need to carry out pre-treatment to Rhizoma Atractylodis Macrocephalae (parched), its processing method: Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui and soaks 24h, taken out by Rhizoma Atractylodis Macrocephalae (parched) after drying, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) is for golden yellow.
First soak 1 day among 30 degree of pure rice wines Scolopendra, Scorpio, Hippocampus being put into 1.5kg, more remaining crude drug is put into above-mentioned pure rice wine, soak and obtain medicated wine after 8 days.
With above-mentioned medicated wine, clinical treatment is carried out to 50 routine hyperosteogeny patients.Instructions of taking: every day is early, middle and late respectively takes two money medicated wine, take period taboo utility beef, spring vegetable, Herba Coriandri etc., the position of taking patient's hyperosteogeny to fortnight can feel there is distending pain sense, and pain day by day, this is normal reaction, adheres to taking, and after the week by the time, pain can slowly reduce, this process illustrate exactly medicine elimination bony spur, at this moment adhere to taking until take to ten jin of medicated wine be a course for the treatment of.The not heavy sick time of the state of an illness just can be cured not long course for the treatment of, and the state of an illness is heavier illly carries out two to three courses for the treatment of.50 routine clinical patients are after treatment, and cure and reach 45 examples, its cure rate reaches 90%.
Embodiment 2
The preparation of crude drug: take Scolopendra 10g, Scorpio 6g, Hippocampus 8g, Radix Aconiti Kusnezoffii Preparata 20g, Radix Angelicae Sinensis 12g, Radix Astragali 5g, Cortex Eucommiae 6g, Radix Rehmanniae 5g, Rhizoma Atractylodis Macrocephalae (parched) 9g, Radix Alangii 15g, Poria cum Radix Pini 19g, Radix Rubiae 10g, Radix Aconiti Preparata 20g, Radix Glycyrrhizae 15g, Rhizoma Arisaematis (processed) 35g, Radix Aucklandiae (Radix Vladimiriae) 16g, Radix Rehmanniae Preparata 9g, Radix Angelicae Pubescentis 10g, Semen Trigonellae 15g, Rhizoma Dioscoreae 10g.Before wherein taking Rhizoma Atractylodis Macrocephalae (parched), need to carry out pre-treatment to Rhizoma Atractylodis Macrocephalae (parched), its processing method: Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui and soaks 24h, taken out by Rhizoma Atractylodis Macrocephalae (parched) after drying, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) is for golden yellow.
First soak 2 days among 40 degree of pure rice wines Scolopendra, Scorpio, Hippocampus being put into 6kg, more remaining crude drug is put into above-mentioned pure rice wine, soak and obtain medicated wine after 7 days.
Carry out clinical treatment with above-mentioned medicated wine to 50 routine hyperosteogeny patients, instructions of taking is identical with embodiment 1.50 routine clinical patients are after treatment, and cure and reach 45 examples, its cure rate reaches 90%.
Embodiment 3
The preparation of crude drug: take Scolopendra 15g, Scorpio 12g, Hippocampus 8g, Radix Aconiti Kusnezoffii Preparata 18g, Radix Angelicae Sinensis 15g, Radix Astragali 6g, Cortex Eucommiae 9g, Radix Rehmanniae 11g, Rhizoma Atractylodis Macrocephalae (parched) 5g, Radix Alangii 18g, Poria cum Radix Pini 16g, Radix Rubiae 13g, Radix Aconiti Preparata 23g, Radix Glycyrrhizae 20g, Rhizoma Arisaematis (processed) 30g, Radix Aucklandiae (Radix Vladimiriae) 14g, Radix Rehmanniae Preparata 11g, Radix Angelicae Pubescentis 25g, Semen Trigonellae 5g, Rhizoma Dioscoreae 15g.Before wherein taking Rhizoma Atractylodis Macrocephalae (parched), need to carry out pre-treatment to Rhizoma Atractylodis Macrocephalae (parched), its processing method: Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui and soaks 24h, taken out by Rhizoma Atractylodis Macrocephalae (parched) after drying, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) is for golden yellow.
First soak 2 days among 35 degree of pure rice wines Scolopendra, Scorpio, Hippocampus being put into 4kg, more remaining crude drug is put into above-mentioned pure rice wine, soak and obtain medicated wine after 7 days.
Carry out clinical treatment with above-mentioned medicated wine to 50 routine hyperosteogeny patients, instructions of taking is identical with embodiment 1.50 routine clinical patients are after treatment, and cure and reach 46 examples, its cure rate reaches 92%.
Embodiment 4
The preparation of crude drug: take Scolopendra 10g, Scorpio 12g, Hippocampus 10g, Radix Aconiti Kusnezoffii Preparata 23g, Radix Angelicae Sinensis 12g, Radix Astragali 8g, Cortex Eucommiae 13g, Radix Rehmanniae 10g, Rhizoma Atractylodis Macrocephalae (parched) 9g, Radix Alangii 17g, Poria cum Radix Pini 18g, Radix Rubiae 12g, Radix Aconiti Preparata 24g, Radix Glycyrrhizae 20g, Rhizoma Arisaematis (processed) 35g, Radix Aucklandiae (Radix Vladimiriae) 13g, Radix Rehmanniae Preparata 14g, Radix Angelicae Pubescentis 18g, Semen Trigonellae 13g, Rhizoma Dioscoreae 15g.Before wherein taking Rhizoma Atractylodis Macrocephalae (parched), need to carry out pre-treatment to Rhizoma Atractylodis Macrocephalae (parched), its processing method: Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui and soaks 24h, taken out by Rhizoma Atractylodis Macrocephalae (parched) after drying, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) is for golden yellow;
First soak 3 days among 35 degree of pure rice wines Scolopendra, Scorpio, Hippocampus being put into 7kg, more remaining crude drug is put into above-mentioned pure rice wine, soak and obtain medicated wine after 7 days.
Carry out clinical treatment with above-mentioned medicated wine to 50 routine hyperosteogeny patients, instructions of taking is identical with embodiment 1.50 routine clinical patients are after treatment, and cure and reach 47 examples, its cure rate reaches 94%.
Embodiment 5
The preparation of crude drug: take Scolopendra 14g, Scorpio 12g, Hippocampus 9g, Radix Aconiti Kusnezoffii Preparata 22g, Radix Angelicae Sinensis 13g, Radix Astragali 7g, Cortex Eucommiae 13g, Radix Rehmanniae 12g, Rhizoma Atractylodis Macrocephalae (parched) 8g, Radix Alangii 16g, Poria cum Radix Pini 17g, Radix Rubiae 12g, Radix Aconiti Preparata 22g, Radix Glycyrrhizae 19g, Rhizoma Arisaematis (processed) 27g, Radix Aucklandiae (Radix Vladimiriae) 14g, Radix Rehmanniae Preparata 11g, Radix Angelicae Pubescentis 18g, Semen Trigonellae 14g, Rhizoma Dioscoreae 10g.Before wherein taking Rhizoma Atractylodis Macrocephalae (parched), need to carry out pre-treatment to Rhizoma Atractylodis Macrocephalae (parched), its processing method: Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui and soaks 12h, taken out by Rhizoma Atractylodis Macrocephalae (parched) after drying, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) is for golden yellow;
First soak 3 days among 40 degree of pure rice wines Scolopendra, Scorpio, Hippocampus being put into 6kg, more remaining crude drug is put into above-mentioned pure rice wine, soak and obtain medicated wine after 8 days.
Carry out clinical treatment with above-mentioned medicated wine to 50 routine hyperosteogeny patients, instructions of taking is identical with embodiment 1.50 routine clinical patients are after treatment, and cure and reach 46 examples, its cure rate reaches 92%.
Concrete case is as follows:
Case 1
Liu, female, 46 years old, Xinhua Lu, Anshun, knee joint hyperosteogeny causes difficulty in walking, after carrying out the treatment of a course for the treatment of, can walk through taking medicated wine of the present invention, and the sense of two knee joint hyperosteogeny tract pain alleviates, again after second course of therapy, arbitrarily can walk, return to one's perfect health.
Case 2
Liu, female, 47 years old, lives Yao Pu town, development zone, Anshun, hyperosteogeny of cervical vertebra, pain is obvious, and carry out the treatment of a course for the treatment of through taking medicated wine of the present invention after, cervical vertebra ache sense obviously alleviates, bend over freely, then after the treatment of second course for the treatment of, cervical vertebra ache sense disappears, and returns to one's perfect health.
Claims (8)
1. treat the Chinese medicine composition of hyperosteogeny for one kind, it is characterized in that, described Chinese medicine composition comprises the crude drug of following weight portion: Scolopendra 5 ~ 15 parts, Scorpio 6 ~ 12 parts, Hippocampus 8 ~ 12 parts, Radix Aconiti Kusnezoffii Preparata 18 ~ 25 parts, Radix Angelicae Sinensis 10 ~ 15 parts, the Radix Astragali 5 ~ 8 parts, the Cortex Eucommiae 6 ~ 14 parts, 5 ~ 13 parts, the Radix Rehmanniae, Rhizoma Atractylodis Macrocephalae (parched) 5 ~ 9 parts, Radix Alangii 12 ~ 18 parts, Poria cum Radix Pini 15 ~ 19 parts, Radix Rubiae 10 ~ 15 parts, Radix Aconiti Preparata 20 ~ 25 parts, 15 ~ 20 parts, Radix Glycyrrhizae, Rhizoma Arisaematis (processed) 25 ~ 35 parts, Radix Aucklandiae (Radix Vladimiriae) 12 ~ 16 parts, 9 ~ 14 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 10 ~ 25 parts, Semen Trigonellae 5 ~ 15 parts, Rhizoma Dioscoreae 10 ~ 15 parts.
2. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 1, it is characterized in that, described Chinese medicine composition comprises the crude drug of following weight portion: Scolopendra 8 ~ 12 parts, Scorpio 10 ~ 12 parts, Hippocampus 8 ~ 10, Radix Aconiti Kusnezoffii Preparata 20 ~ 25 parts, Radix Angelicae Sinensis 10 ~ 13 parts, the Radix Astragali 6 ~ 8 parts, the Cortex Eucommiae 8 ~ 14 parts, 7 ~ 11 parts, the Radix Rehmanniae, Rhizoma Atractylodis Macrocephalae (parched) 7 ~ 9 parts, Radix Alangii 15 ~ 18 parts, Poria cum Radix Pini 17 ~ 19 parts, Radix Rubiae 12 ~ 15 parts, Radix Aconiti Preparata 22 ~ 25 parts, 18 ~ 20 parts, Radix Glycyrrhizae, Rhizoma Arisaematis (processed) 30 ~ 35 parts, Radix Aucklandiae (Radix Vladimiriae) 12 ~ 14 parts, 12 ~ 14 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 15 ~ 25 parts, Semen Trigonellae 10 ~ 15 parts, Rhizoma Dioscoreae 12 ~ 15 parts.
3. the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 2, it is characterized in that, described Chinese medicine composition comprises the crude drug of following weight portion: Scolopendra 10 parts, Scorpio 12 parts, Hippocampus 10 parts, Radix Aconiti Kusnezoffii Preparata 23 parts, Radix Angelicae Sinensis 12 parts, the Radix Astragali 8 parts, the Cortex Eucommiae 13 parts, 10 parts, the Radix Rehmanniae, Rhizoma Atractylodis Macrocephalae (parched) 9 parts, Radix Alangii 17 parts, Poria cum Radix Pini 18 parts, Radix Rubiae 12 parts, Radix Aconiti Preparata 24 parts, 20 parts, Radix Glycyrrhizae, Rhizoma Arisaematis (processed) 35 parts, Radix Aucklandiae (Radix Vladimiriae) 13 parts, 14 parts, Radix Rehmanniae Preparata, Radix Angelicae Pubescentis 18 parts, Semen Trigonellae 13 parts, Rhizoma Dioscoreae 15 parts.
4. the Chinese medicine composition of the treatment hyperosteogeny as described in as arbitrary in claims 1 to 3, is characterized in that, also comprise the pure rice wine that the number of degrees are 35 ~ 40.
5. the preparation method of the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 4, is characterized in that, comprise the following steps:
(1) Rhizoma Atractylodis Macrocephalae (parched) is placed in salt Jiang Shui to soak, then the Rhizoma Atractylodis Macrocephalae (parched) taking-up after soaking is dried, big fire stir-fries until Rhizoma Atractylodis Macrocephalae (parched) becomes golden yellow;
(2) Scolopendra, Scorpio, Hippocampus are put among described pure rice wine and soak 1 ~ 3 day;
(3) step (1) gained Rhizoma Atractylodis Macrocephalae (parched) and remaining crude drug are put into step (2) described pure rice wine, soak 5 ~ 9 days.
6. the preparation method of the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 5, it is characterized in that, the weight of described pure rice wine is 4 ~ 7kg.
7. the preparation method of the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 5, it is characterized in that, the time of soaking in described step (1) is 2 ~ 3 days.
8. the preparation method of the Chinese medicine composition for the treatment of hyperosteogeny as claimed in claim 5, it is characterized in that, the time of soaking in described step (3) is 6 ~ 8 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410608117.8A CN104491319A (en) | 2014-11-03 | 2014-11-03 | Traditional Chinese medicine composition treating hyperosteogeny and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410608117.8A CN104491319A (en) | 2014-11-03 | 2014-11-03 | Traditional Chinese medicine composition treating hyperosteogeny and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491319A true CN104491319A (en) | 2015-04-08 |
Family
ID=52932833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410608117.8A Pending CN104491319A (en) | 2014-11-03 | 2014-11-03 | Traditional Chinese medicine composition treating hyperosteogeny and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491319A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181449A (en) * | 2007-11-23 | 2008-05-21 | 苏华艳 | Medicine liqueur for curing osteoproliferation |
| CN103656336A (en) * | 2012-09-18 | 2014-03-26 | 范暄民 | Traditional Chinese medicine for treating hyperostosis |
-
2014
- 2014-11-03 CN CN201410608117.8A patent/CN104491319A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181449A (en) * | 2007-11-23 | 2008-05-21 | 苏华艳 | Medicine liqueur for curing osteoproliferation |
| CN103656336A (en) * | 2012-09-18 | 2014-03-26 | 范暄民 | Traditional Chinese medicine for treating hyperostosis |
Non-Patent Citations (1)
| Title |
|---|
| 何开仁，等: "龙须风湿灵治疗肩周炎、骨质增生", 《云南中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104147542A (en) | Plaster for treating rheumatic rheumatoid arthritis, and preparation method thereof | |
| CN103191377A (en) | Plaster for treating rheumatoid bone diseases | |
| CN103211932B (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN102727833B (en) | Plaster for treating rheumatoid bone disease | |
| CN100446796C (en) | Externally applied pharmaceutical for bone fracture | |
| CN103054965B (en) | External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster | |
| CN102872226B (en) | Traditional Chinese medicine composition for treating arthralgia | |
| CN103690711A (en) | Medicinal wine for dispersing pathogenic wind and activating collaterals | |
| CN1969959A (en) | Externally applied medicament for treating bone fracture | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN106540229A (en) | A kind of exterior-applied medical wine for treating cold pain disease and preparation method thereof | |
| CN101926977A (en) | Medicament for expelling wind, removing dampness, activating blood and relieving pain | |
| CN102416049B (en) | Small square type rheumatoid swelling diminishing and pain eliminating plaster and preparation method thereof | |
| CN104491319A (en) | Traditional Chinese medicine composition treating hyperosteogeny and preparation method thereof | |
| CN104873615A (en) | Cinnamon oil containing externally applied medicine for treating traumatic injury | |
| CN104274785A (en) | Traditional Chinese medicine preparation for hand tendon injuries and preparation method thereof | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN105434621A (en) | A medicine for treating tinea of feet | |
| CN103705629B (en) | A kind of Chinese medicine composition for the treatment of pruritus | |
| CN101439165B (en) | Plaster for treating bone fracture and preparation method thereof | |
| CN102908535B (en) | One treats lumbago and skelalgia medicated wine | |
| CN105560427A (en) | Transdermal gate-freeing powder | |
| CN100346810C (en) | Chinese medicinal preparation for treating traumatic injury and its preparation process | |
| CN104688893A (en) | Medicated bath decoction for treating cold-damp invasion type external humeral epicondylitis and preparation method thereof | |
| CN104491479A (en) | Medicinal liquor for treating arthritis and back and leg pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20190611 |